About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« J&J Shrinks Their Labs Again | Main | The Future is Unwritten »

July 13, 2006

A Friday Linkfest

Email This Entry

Posted by Derek

There are a lot of interesting blogs that I need to catch up with, so here we go. First off is On Pharma, which focuses on the manufacturing end of things, with a lot of good stuff about FDA approvals and the clinical world. Note this recent post on the "cGMP Priesthood", which is something I fortunately don't have to deal with.

Life of a Lab Rat is a view from the bench in Sydney (no, not the beach, the bench), and Pipette Monkeys provides one from Heidelberg. Is This Thing On? has a biotech/bioinformatic perspective, and I've been wondering when someone was finally going to invent the Eastern Blot. And finally, the group at Nobel Intent is always worth checking.

Update: And how could I forget The Chemblog?

Comments (5) + TrackBacks (0) | Category: Blog Housekeeping


1. Kyle Finchsigmate on July 14, 2006 2:57 AM writes...

That's it buddy. You're on the list.

Permalink to Comment

2. Black Knight on July 14, 2006 5:39 AM writes...

I second that emotion.

Permalink to Comment

3. JSinger on July 14, 2006 8:41 AM writes...

There are periodic attempts to claim "Eastern blot" for various post-translational modifications, but it never really caught on.

Permalink to Comment

4. Eva on July 14, 2006 9:12 AM writes...

You would not want to know how often I get visitors through Google looking for "what is an eastern blot".

Permalink to Comment

5. Cryptic Ned on July 16, 2006 12:49 PM writes...

Boy, I read about five posts about "cGMP" on that site before I realized that it wasn't talking about cGMP. I was wondering why I hadn't heard before about how important this particular second messenger was as a drug target.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry